The data is part of an ongoing national lab survey the CDC started in March to test for antibodies against SARS-CoV-2, the virus that causes COVID-19, in commercial lab samples. More than 26,000 lab samples have been tested to show a 79.7 percent prevalence rate, indicating 56,977,000 children have had at least one COVID-19 infection.
The study only researches the detection of antibodies; the antibody percentage, which would indicate someone’s level of protection against infection, is not calculated.
Among the young population, the age groups demonstrated similar antibody levels. Children 5 to 11 years old were the age group with the highest prevalence of SARS-CoV-2 antibodies, with an 82.5 percent prevalence rate in tested samples. Infants between 6 months and 4 years old accounted for a 74 percent prevalence rate.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.